Style | Citing Format |
---|---|
MLA | Mehraeen E, et al.. "Estimating Methods of the Undetected Infections in the Covid-19 Outbreak: A Systematic Review." Infectious Disorders - Drug Targets, vol. 23, no. 4, 2023, pp. 19-36. |
APA | Mehraeen E, Pashaei Z, Akhtaran FK, Dashti M, Afzalian A, Ghasemzadeh A, Asili P, Kahrizi MS, Mirahmad M, Rahimi E, Matini P, Afsahi AM, Dadras O, Seyed Alinaghi SA (2023). Estimating Methods of the Undetected Infections in the Covid-19 Outbreak: A Systematic Review. Infectious Disorders - Drug Targets, 23(4), 19-36. |
Chicago | Mehraeen E, Pashaei Z, Akhtaran FK, Dashti M, Afzalian A, Ghasemzadeh A, Asili P, et al.. "Estimating Methods of the Undetected Infections in the Covid-19 Outbreak: A Systematic Review." Infectious Disorders - Drug Targets 23, no. 4 (2023): 19-36. |
Harvard | Mehraeen E et al. (2023) 'Estimating Methods of the Undetected Infections in the Covid-19 Outbreak: A Systematic Review', Infectious Disorders - Drug Targets, 23(4), pp. 19-36. |
Vancouver | Mehraeen E, Pashaei Z, Akhtaran FK, Dashti M, Afzalian A, Ghasemzadeh A, et al.. Estimating Methods of the Undetected Infections in the Covid-19 Outbreak: A Systematic Review. Infectious Disorders - Drug Targets. 2023;23(4):19-36. |
BibTex | @article{ author = {Mehraeen E and Pashaei Z and Akhtaran FK and Dashti M and Afzalian A and Ghasemzadeh A and Asili P and Kahrizi MS and Mirahmad M and Rahimi E and Matini P and Afsahi AM and Dadras O and Seyed Alinaghi SA}, title = {Estimating Methods of the Undetected Infections in the Covid-19 Outbreak: A Systematic Review}, journal = {Infectious Disorders - Drug Targets}, volume = {23}, number = {4}, pages = {19-36}, year = {2023} } |
RIS | TY - JOUR AU - Mehraeen E AU - Pashaei Z AU - Akhtaran FK AU - Dashti M AU - Afzalian A AU - Ghasemzadeh A AU - Asili P AU - Kahrizi MS AU - Mirahmad M AU - Rahimi E AU - Matini P AU - Afsahi AM AU - Dadras O AU - Seyed Alinaghi SA TI - Estimating Methods of the Undetected Infections in the Covid-19 Outbreak: A Systematic Review JO - Infectious Disorders - Drug Targets VL - 23 IS - 4 SP - 19 EP - 36 PY - 2023 ER - |